{ "items": [ "\n\n
Revell AD. et al, (2021), The Journal of antimicrobial chemotherapy, 76, 1898 - 1906
\n \n \n \n\n \n
\n \n \nLimato R. et al, (2021), JAC-antimicrobial resistance, 3
\n \n \n \n\n \n
\n \n \nHorby PW. et al, (2021)
\n \n \n \n\n \n
\n \n \nvan Crevel R. et al, (2021), Tuberculosis, 128, 102085 - 102085
\n \n \n \n\n \n
\n \n \nSurendra H. et al, (2021), The Lancet Regional Health - Western Pacific, 9, 100108 - 100108
\n \n \n \n\n \n
\n \n \nSchilling WHK. et al, (2021), Wellcome Open Research, 6, 71 - 71
\n \n \n \n\n \n
\n \n \nSchilling WH. et al, (2021), Wellcome open research, 6
\n \n \n \n\n \n
\n \n \nKroeze S. et al, (2020), The Journal of infectious diseases
\n \n \n \n\n \n
\n \n \nHemelaar J. et al, (2020), Journal of Virology, 95
\n \n \n \n\n \n
\n \n \nDonovan J. et al, (2020), Clinical Infectious Diseases, 71, 2002 - 2005
\n \n \n \n\n \n
\n \n \nHemelaar J. et al, (2020), The Lancet HIV, 7, e772 - e781
\n \n \n \n\n \n
\n \n \nMarais S. et al, (2020), Wellcome Open Research, 4, 190 - 190
\n \n \n \n\n \n
\n \n \nInzaule SC. et al, (2020), AIDS (London, England), 34, 1559 - 1566
\n \n \n \n\n \n
\n \n \nTurner P. et al, (2020), Wellcome Open Research, 5, 13 - 13
\n \n \n \n\n \n
\n \n \nInzaule SC. et al, (2020), The lancet. HIV, 7, e316 - e317
\n \n \n \n\n \n
\n \n \nMbunkah HA. et al, (2020), The Journal of infectious diseases, 221, 1584 - 1597
\n \n \n \n\n \n
\n \n \nDjaafara B. et al, (2020), SSRN Electronic Journal
\n \n \n \n\n \n
\n \n \nDonovan J. et al, (2020), Wellcome Open Research, 4, 163 - 163
\n \n \n \n\n \n
\n \n \nTurner P. et al, (2020), Wellcome Open Research, 5, 13 - 13
\n \n \n \n\n \n
\n \n \nTurner P. et al, (2020), Wellcome open research, 5
\n \n \n \n\n \n
\n \n \n